The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

被引：0
|
作者：
Anaïs Chauvin
Chang-Shu Wang
Sameh Geha
Perrine Garde-Granger
Alex-Ane Mathieu
Vincent Lacasse
François-Michel Boisvert
机构：
[1] Université de Sherbrooke,Department of Anatomy and Cell Biology, Faculty of Medicine and Health Sciences
[2] Université de Sherbrooke,Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences
[3] Université de Sherbrooke,Department of Pathology, Faculty of Medicine and Health Sciences
来源：
Clinical Proteomics | 2018年 / 15卷
关键词：
Rectal cancer; Resistance to neoadjuvant radio-chemotherapy; 5-Fluorouracil; Proteomics; Mass spectrometry; Predictive biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer
    Videtic, GMM
    Fisher, BJ
    Perera, FE
    Bauman, GS
    Kocha, WI
    Taylor, M
    Vincent, MD
    Plewes, EA
    Engel, CJ
    Stitt, LW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (02): : 319 - 324
  • [42] Usefulness of Perfusion CT to Assess Response to Neoadjuvant Combined Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
    Curvo-Semedo, Luis
    Antonia Portilha, M.
    Ruivo, Catarina
    Borrego, Margarida
    Leite, Julio S.
    Caseiro-Alves, Filipe
    ACADEMIC RADIOLOGY, 2012, 19 (02) : 203 - 213
  • [43] Predictive factors for early distant metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
    Park, Hyojung
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (04) : 252 - 264
  • [44] Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model
    Sun, Yanwu
    Wu, Xuejing
    Lin, Huiming
    Lu, Xingrong
    Huang, Ying
    Chi, Pan
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (04) : 1019 - 1028
  • [45] Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
    Dreussi, Eva
    Pucciarelli, Salvatore
    De Paoli, Antonino
    Polesel, Jerry
    Canzonieri, Vincenzo
    Agostini, Marco
    Friso, Maria Luisa
    Belluco, Claudio
    Buonadonna, Angela
    Lonardi, Sara
    Zanusso, Chiara
    De Mattia, Elena
    Toffoli, Giuseppe
    Cecchin, Erika
    ONCOTARGET, 2016, 7 (15) : 19781 - 19793
  • [46] Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
    Zhang, Chongda
    Ye, Feng
    Liu, Yuan
    Ouyang, Han
    Zhao, Xinming
    Zhang, Hongmei
    ONCOTARGET, 2018, 9 (04) : 4862 - 4874
  • [47] Real-world outcomes for neoadjuvant capecitabine versus infusional 5-fluorouracil in the treatment of locally advanced rectal cancer
    Loft, Matthew
    Wong, Hui-Li
    Kosmider, Suzanne
    Lee, Margaret
    Tie, Jeanne
    Wong, Rachel
    Jones, Ian T.
    Croxford, Matthew
    Steel, Malcolm
    Faragher, Ian
    Guerrieri, Mario
    Christie, Michael
    Gibbs, Peter
    INTERNAL MEDICINE JOURNAL, 2021, 51 (08) : 1262 - 1268
  • [48] Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase Ⅱ study
    Zeynep Gural
    Sezer Saglam
    Serap Yucel
    Esra Kaytan-Saglam
    Oktar Asoglu
    Cetin Ordu
    Hediye Acun
    Rasul Sharifov
    Semen Onder
    Ahmet Kizir
    Ethem N Oral
    World Journal of Gastrointestinal Oncology, 2018, 10 (01) : 40 - 47
  • [49] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
    Manabu Emi
    Jun Hihara
    Yoichi Hamai
    Yoshiro Aoki
    Morihito Okada
    Masahiro Kenjo
    Yuji Murakami
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1499 - 1505
  • [50] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
    Emi, Manabu
    Hihara, Jun
    Hamai, Yoichi
    Aoki, Yoshiro
    Okada, Morihito
    Kenjo, Masahiro
    Murakami, Yuji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1499 - 1505
12345